Insulet Corporation Share Price
Equities
PODD
US45784P1012
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 296.19 USD | -2.73% |
|
-4.71% | +13.45% |
| 09/12 | Insulet Insider Bought Shares Worth $299,884, According to a Recent SEC Filing | MT |
| 04/12 | Insulet announces FDA 510(k) clearance of Omnipod 5 algorithm enhancements | RE |
| Capitalization | 2.08TCr 1.79TCr 1.68TCr 1.57TCr 2.89TCr 1,87800Cr 3.15TCr 20TCr 7.6TCr 89TCr 7.82TCr 7.65TCr 3,24900Cr | P/E ratio 2025 * |
85x | P/E ratio 2026 * | 48.1x |
|---|---|---|---|---|---|
| Enterprise value | 2.11TCr 1.81TCr 1.7TCr 1.58TCr 2.92TCr 1,89900Cr 3.18TCr 20TCr 7.68TCr 90TCr 7.91TCr 7.74TCr 3,28500Cr | EV / Sales 2025 * |
7.83x | EV / Sales 2026 * | 6.37x |
| Free-Float |
99.46% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Insulet Corporation
| 1 day | -2.73% | ||
| 1 week | -4.71% | ||
| Current month | -9.47% | ||
| 1 month | -7.39% | ||
| 3 months | -15.27% | ||
| 6 months | -5.00% | ||
| Current year | +13.45% |
| 1 week | 295.16 |  | 317.34 |
| 1 month | 295.16 | | 354.88 |
| Current year | 230.05 | | 354.88 |
| 1 year | 230.05 | | 354.88 |
| 3 years | 125.82 | | 354.88 |
| 5 years | 125.82 | | 354.88 |
| 10 years | 23.94 | | 354.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ashley McEvoy
CEO | Chief Executive Officer | 54 | 28/04/2025 |
Flavia Pease
DFI | Director of Finance/CFO | 52 | 30/09/2025 |
Laetitia Cousin
CMP | Compliance Officer | 49 | 01/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Timothy Scannell
CHM | Chairman | 60 | 01/01/2019 |
Jessica Hopfield
BRD | Director/Board Member | 60 | 27/07/2015 |
Michael Minogue
BRD | Director/Board Member | 58 | 10/08/2017 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.73% | -4.71% | +11.57% | -2.36% | 2.14TCr | |
| -2.39% | -4.62% | +5.61% | +14.19% | 22TCr | |
| -0.10% | -2.01% | +20.53% | +30.17% | 13TCr | |
| -0.54% | -6.19% | +38.79% | +98.18% | 6.59TCr | |
| -1.77% | -1.21% | -13.87% | -23.58% | 5.54TCr | |
| -0.56% | +0.57% | +17.42% | +71.25% | 5.2TCr | |
| -0.71% | -0.56% | +21.08% | +37.38% | 2.58TCr | |
| +0.20% | +3.31% | -15.57% | -46.51% | 2.55TCr | |
| -0.84% | +1.63% | +17.63% | -33.20% | 2.41TCr | |
| -0.87% | -1.96% | -23.74% | +18.27% | 2.25TCr | |
| Average | -1.03% | -1.53% | +7.95% | +16.38% | 6.4TCr | |
| Weighted average by Cap. | -1.26% | -2.65% | +10.73% | +23.77% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 269.14Cr 231.68Cr 217.49Cr 202.17Cr 372.66Cr 24TCr 406.57Cr 2.53TCr 981.4Cr 11TCr 1.01TCr 988.51Cr 42TCr | 324.17Cr 279.05Cr 261.96Cr 243.51Cr 448.86Cr 29TCr 489.69Cr 3.05TCr 1.18TCr 14TCr 1.22TCr 1.19TCr 51TCr |
| Net income | 25Cr 21Cr 20Cr 19Cr 35Cr 2.25TCr 38Cr 235.1Cr 91Cr 1.06TCr 94Cr 92Cr 3.89TCr | 43Cr 37Cr 35Cr 33Cr 60Cr 3.92TCr 66Cr 409.41Cr 158.54Cr 1.85TCr 163.18Cr 159.68Cr 6.78TCr |
| Net Debt | 23Cr 20Cr 18Cr 17Cr 31Cr 2.05TCr 34Cr 213.62Cr 83Cr 965.57Cr 85Cr 83Cr 3.54TCr | -17Cr -15Cr -14Cr -13Cr -24Cr -1.57TCr -26Cr -163.75Cr -63Cr -740.15Cr -65Cr -64Cr -2.71TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/25/08 | 296.19 $ | -2.73% | 6,44,327 |
| 05/25/05 | 304.49 $ | -3.62% | 5,18,069 |
| 04/25/04 | 315.92 $ | +2.72% | 7,57,061 |
| 03/25/03 | 307.56 $ | -0.47% | 9,05,108 |
| 02/25/02 | 309.00 $ | -0.59% | 7,59,484 |
Delayed Quote Nasdaq, December 09, 2025 at 02:30 am IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PODD Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition